Praxis Precision Medicines Reports Positive Results of
In the 45 mg cohort, 100% of patients achieved a complete response In the 15 mg cohort, 80% of patients achieved a complete response and 20% achieved a...
Source: globenewswire.com
Focal Epilepsy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Focal Epilepsy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Focal Epilepsy Today - Breaking & Trending Today
Praxis Precision Medicines Reports Positive Results of PRAX-628 Study Evaluating Photo Paroxysmal Response Achieving 100% Response in Treated Patients
Praxis Precision Medicines, Inc. provided an update on its Phase 2a proof of concept study evaluating PRAX-628 in epilepsy patients with PPR. PPR studies measure electroencephalogram signatures after...
Source: marketscreener.com
Biohaven Presents Expanded EEG and Safety Data for BHV-7000 at the American Epilepsy Society Annual Meeting
Biohaven reported full results from the BHV-7000 Phase 1 study examining doses up to 120 mg daily, demonstrating BHV-7000 was well-tolerated at all doses...
Source: prnewswire.com
New drug may reduce frequency of seizures in epilepsy
For people with tough-to-treat epilepsy, seizures can be both frightening and dangerous, but a new experimental pill may bring significant relief to over one-third of them.
Source: yahoo.com
Seizures While Driving: Need for Early Epilepsy Diagnosis
Discover the risks of seizures while driving, the delayed diagnosis of epilepsy, and the importance of early identification for road safety.
Source: medindia.net